Nextleaf Solutions Ltd (CSE:OILS) (OTCQB:OILFF) CEO Paul Pedersen tells Proactive the group has begun human trials of cannabis vapes. Pedersen says under its amended Cannabis Research Licence from Health Canada, the company is collecting sensory evaluation data from qualified volunteers completing organoleptic assessments of a wide variety of formulated cannabis vape products. It expects to accelerate product development and drastically shorten design cycles for launching new cannabis vape products by validating formulations and delivery technologies more efficiently.
Nextleaf Solutions CEO describes the importance of its cannabis vape human trials launch
